SCHEMBL14640350

SCHEMBL14640350

CCCCCCCCCCCCN(C)C(CCCCCCCC)C(C)N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SPHK1 Q9NYA1 2/20 0.47
▸ OPRM1 P35372 1/20 0.45
▸ PLA2G1B P04054 1/20 0.44
▸ PLA2G2A P14555 1/20 0.44
▸ DNM1 Q05193 4/20 0.41
▸ TP53 P04637 2/20 0.37
▸ CYP2D6 P10635 2/20 0.36
▸ GMNN O75496 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ THPO P40225 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CETP P11597 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ UBE2N P61088 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14624342 0.83 PLA2G1B (0.43) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL27449911 0.82 DNM1 (0.43) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL27449909 0.82 DNM1 (0.43) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL27449951 0.82 DNM1 (0.43) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL27449872 0.82 DNM1 (0.43) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL9400807 0.81 SPHK1 (0.38) SPHK1OPRM1DNM1TP53CYP2D6
SCHEMBL10674908 0.79 DNM1 (0.48) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL5539887 0.79 DNM1 (0.48) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL28601890 0.79 DNM1 (0.48) SPHK1OPRM1PLA2G1BPLA2G2ADNM1
SCHEMBL5544687 0.79 DNM1 (0.48) SPHK1OPRM1PLA2G1BPLA2G2ADNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007002635-A2 C-LINKED CYCLIC ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-04 — — WO disclosed
Send feedback